Collaborative Drug Discovery is working with Lilly TuneLab to make Lilly AI/ML models available in the CDD Vault

BURLINGAME, California., May 20, 2026 /PRNewswire/ — Collaborative Drug Discovery (CDD), the leading provider of data management solutions for the pharmaceutical and biotechnology industries, today announced an agreement with Eli Lilly and Company (Lilly) to integrate Lilly TuneLab, a collaborative AI/ML drug discovery platform, into CDD Vault.

Lilly TuneLab was created by Lilly to accelerate biotech innovation by giving participating companies access to models based on decades of Lilly’s proprietary research data. Through this agreement, biotech companies using CDD Vault will be able to leverage select Lilly predictive models in their science workflows.

“By integrating TuneLab directly into CDD Vault, we advance CDD’s core vision of enabling collaboration between drug discovery teams and organizations. We believe that solving the most complex challenges in drug discovery will depend on innovative collaboration models that…